phenyl aminosalicylate (pheny-pas-tebamin) Report issue

Small molecule Approved FDA
ChEMBL Drug Central Drugs@FDA KEGG PubChem

Active Ingredient History

NOW
  • Now
Phenyl Aminosalicylate is the phenyl ester of para-aminosalicylic acid, reported to have less side effects than simple salts of para-aminosalicylic acid. It’s a second-line antituberculosis drug with a high incidence of hypersensitivity reactions and gastrointestinal upset.   NCATS

Chemistry

  • SMILES: NC1=CC=C(C(=O)OC2=CC=CC=C2)C(O)=C1
  • InChIKey: DNVVZWSVACQWJE-UHFFFAOYSA-N
  • Mol. Mass: 229.2313
  • ALogP: 2.19
  • ChEMBL Molecule:
    phenyl aminosalicylate  
More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Discontinued
  • Delivery Methods: Oral
  • Pro Drug: No

Alternative names

fenamisal | p-aminosalicylic acid phenyl ester | phenyl aminosalicylate | phenyl p-aminosalicylate | pheny-pas-tebamin | tebamin | tebanyl

Organizations (2)

Research & Development (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (2)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (1)

Approved Indications (1)


 

Tuberculosis

Experimental Indications - Clinical Trial Phases 1-4 (0)

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue